In February, 2014 Crescendo Biosciences, Inc. was acquired by Myriad Genetics and continues to operate as a wholly-owned subsidiary. Myriad Geneics Formerly known as Riley Genomics Inc, Crescendo Bioscience is developing quantitative, objective diagnostic tests to provide rheumatologists with deeper clinical insights into individual disease biology. Corporate faciliities are in San Francisco; research labs are in Oklahoma. The firm is creating comprehensive models of disease biology through deep expertise in genetics, gene expression, and quantitative protein analysis. Crescendo is working with physicians, clinical researchers, healthcare administrators, and others to develop an overall strategy that offers: valuable information on individual disease biology to enable rheumatologists and their patients to manage disease, comprehensive test reports to facilitate patient management based on a full assessment of both biology and clinical disease manifestations, and longitudinal tracking of chronic disease.
